Egan JW - Search Results

1

Method for quantification of myocardial infarction and inflammatory cell infiltration in rat cardiac tissue.

Griswold DE, Hillegass LM, Hill DE, Egan JW, Smith EF 3rd. Griswold DE, et al. Among authors: egan jw. J Pharmacol Methods. 1988 Nov;20(3):225-35. doi: 10.1016/0160-5402(88)90065-4. J Pharmacol Methods. 1988. PMID: 2853255

2

Identification of cardiac endothelin binding sites in rats: downregulation of left atrial endothelin binding sites in response to myocardial infarction.

Nambi P, Pullen M, Egan JW, Smith EF 3rd. Nambi P, et al. Among authors: egan jw. Pharmacology. 1991;43(2):84-9. doi: 10.1159/000138832. Pharmacology. 1991. PMID: 1663622

3

Reduction in myocardial ischemic/reperfusion injury and neutrophil accumulation after therapeutic administration of streptokinase.

Smith EF 3rd, Nichols AJ, Sellers TS, O'Brien SR, Griswold DE, Egan JW, Hillegass LM, Vasko JA, Slivjak MJ, Davis PA, et al. Smith EF 3rd, et al. Among authors: egan jw. J Cardiovasc Pharmacol. 1991 Nov;18(5):729-38. doi: 10.1097/00005344-199111000-00011. J Cardiovasc Pharmacol. 1991. PMID: 1723770

4

SK&F S-106203 inhibits leukotriene C4, leukotriene D4 and leukotriene E4 vasopressor responses in the conscious rat.

Smith EF 3rd, Slivjak MJ, Egan JW, Eckardt RD, Newton JF. Smith EF 3rd, et al. Among authors: egan jw. Br J Pharmacol. 1990 Jun;100(2):195-200. doi: 10.1111/j.1476-5381.1990.tb15781.x. Br J Pharmacol. 1990. PMID: 2165834 Free PMC article.

5

Reduction of myocardial damage and polymorphonuclear leukocyte accumulation following coronary artery occlusion and reperfusion by the thromboxane receptor antagonist BM 13.505.

Smith EF 3rd, Griswold DE, Egan JW, Hillegass LM, DiMartino MJ. Smith EF 3rd, et al. Among authors: egan jw. J Cardiovasc Pharmacol. 1989 May;13(5):715-22. J Cardiovasc Pharmacol. 1989. PMID: 2472519

6

Effect of propranolol on ischemic myocardial damage and left ventricular hypertrophy following permanent coronary artery occlusion or occlusion followed by reperfusion.

Smith EF 3rd, Egan JW, Griswold DE. Smith EF 3rd, et al. Among authors: egan jw. Pharmacology. 1989;38(5):298-309. doi: 10.1159/000138550. Pharmacology. 1989. PMID: 2527373

7

Reduction of myocardial damage and polymorphonuclear leukocyte accumulation following coronary artery occlusion and reperfusion by the thromboxane receptor antagonist BM 13.505.

Griswold DE, Egan JW, Earl CQ, Hillegass LM, Marshall PJ, Smith EF 3rd. Griswold DE, et al. Among authors: egan jw. Prog Clin Biol Res. 1989;301:161-5. Prog Clin Biol Res. 1989. PMID: 2529547 No abstract available.

8

BM 13.505, a selective thromboxane receptor antagonist, reduces myocardial infarct size following coronary artery reperfusion.

Smith EF 3rd, Earl CQ, Egan JW. Smith EF 3rd, et al. Among authors: egan jw. Prostaglandins Leukot Essent Fatty Acids. 1989 Oct;38(1):15-23. doi: 10.1016/0952-3278(89)90142-7. Prostaglandins Leukot Essent Fatty Acids. 1989. PMID: 2532749

9

Selective antagonism of peptidoleukotriene responses does not reduce myocardial damage or neutrophil accumulation following coronary artery occlusion with reperfusion.

Egan JW, Griswold DE, Hillegass LM, Newton JF, Eckardt RD, Slivjak MJ, Smith EF 3rd. Egan JW, et al. Prostaglandins. 1989 May;37(5):597-613. doi: 10.1016/0090-6980(89)90075-0. Prostaglandins. 1989. PMID: 2544926

10

Effect of a selective V1 vasopressin receptor antagonist on the sequelae of endotoxemia in the conscious rat.

Egan JW, Jugus M, Kinter LB, Lee K, Smith EF 3rd. Egan JW, et al. Circ Shock. 1989 Oct;29(2):155-66. Circ Shock. 1989. PMID: 2684446

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

29 results

Search Page

Filters